Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 11NIH 4NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Thoracic 1Other hematologic neoplasm 1

Conditions

Neoplasms 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphadenopathy 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1HIV Infections 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 283Magnetic Resonance Spectroscopy 194Biopsy 163Nivolumab 42pembrolizumab 36Radiation 36Cyclophosphamide 35X-Rays 34Immunoglobulin G 34Disulfides 34Cisplatin 32Taxes 31Paclitaxel 31Platinum 301,2-diaminocyclohexaneplatinum II citrate 30Radiotherapy 29Carboplatin 29Doxorubicin 28atezolizumab 24Gemcitabine 24venetoclax 21Bevacizumab 20olaparib 18fludarabine 18Ipilimumab 18CTLA-4 Antigen 18cabozantinib 17Vincristine 17Prednisone 16Dexamethasone 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Filgrastim × 30 days × Clear all
NCT07012044 2026-05-27

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1 Recruiting
47 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
29 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

NCT00092222 2026-05-22

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT03907488 2026-05-04

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
994 enrolled 11 charts 1 FDA
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡